Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Status:
NOT_YET_RECRUITING
Trial end date:
2029-12-31
Target enrollment:
Participant gender:
Summary
Efficacy evaluation of camrelizumab combined with chemotherapy for adjuvant treatment of patients with pathologically confirmed lymph node-positive cervical cancer after staging surgery.
Phase:
PHASE2
Details
Lead Sponsor:
Women's Hospital School Of Medicine Zhejiang University